Skip to main content
Fig. 1 | Trials

Fig. 1

From: Effect of preconceptional orlistat treatment on in-vitro fertilization outcome in overweight/obese women: study protocol for a randomized controlled trial

Fig. 1

SPIRIT diagram for schedule of enrollment, interventions, and assessments. Safety assessment includes fasting blood glucose, insulin, TG, TC, HDL, LDL, Lp (a), liver function, renal function, CBC, coagulation test, HBV, HCV, HIV, syphilis, and routine urine. t1, 1–3 months after allocation; t2, day of ET; t3, 2 weeks after ET; t4, 5 weeks after ET; t5, 10 weeks after ET; t6, 28 weeks of gestation; t7, 37 weeks of gestation; t8, delivery; t9, 6 weeks after delivery

Back to article page

Trials

ISSN: 1745-6215